Filed: 11/7/2022ACC: 0001140361-22-040121
π What this filing means
AJU IB INVESTMENT CO., LTD. filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $58.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$58.4K
Total AUM (reported)
4.35M
Total Shares
Allocation by class
COM$26.2K44.8%
COMMON STOCK$25.9K44.4%
COM CL A$6.3K10.8%
Portfolio Concentration
Top 3$46.8K80.1%
4β10$11.6K19.9%
Top 3 weight
80.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4.35M
Sole
Full voting authority
4.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
ARCELLX INC
SOLEShares1.38M
TypeSH
Market value$25.9K
44.37%
Sole
1.38M
Shared
0.00
None
0.00
RALLYBIO CORP
SOLEShares754.68K
TypeSH
Market value$10.9K
18.69%
Sole
754.68K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares457.06K
TypeSH
Market value$9.9K
17.03%
Sole
457.06K
Shared
0.00
None
0.00
SEER INC
SOLEShares816.38K
TypeSH
Market value$6.3K
10.82%
Sole
816.38K
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares99.50K
TypeSH
Market value$2.4K
4.10%
Sole
99.50K
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares667.74K
TypeSH
Market value$1.9K
3.33%
Sole
667.74K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares175K
TypeSH
Market value$971.00
1.66%
Sole
175K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARCELLX INCSOLE | COMMON STOCK | 1.38M | SH | $25.9K 44.37% | 1.38M | 0.00 | 0.00 |
RALLYBIO CORPSOLE | COM | 754.68K | SH | $10.9K 18.69% | 754.68K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 457.06K | SH | $9.9K 17.03% | 457.06K | 0.00 | 0.00 |
SEER INCSOLE | COM CL A | 816.38K | SH | $6.3K 10.82% | 816.38K | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 99.50K | SH | $2.4K 4.10% | 99.50K | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 667.74K | SH | $1.9K 3.33% | 667.74K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 175K | SH | $971.00 1.66% | 175K | 0.00 | 0.00 |